276 related articles for article (PubMed ID: 5471527)
1. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
[No Abstract] [Full Text] [Related]
2. [The development of sulfonylurea late resistance].
Angeli I
Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
[No Abstract] [Full Text] [Related]
3. [Our experience with Daonil. A new oral hypoglycemic agent].
Rodriguez-Miñon JL; Arrieta F; Herrera JL
Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
[No Abstract] [Full Text] [Related]
4. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
Marocco F; Patrito G
Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
[No Abstract] [Full Text] [Related]
5. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
[No Abstract] [Full Text] [Related]
6. Clinical experience with glybenclamide in 100 non-ketotic diabetics.
Sahgal VK; Ahuja MM
Indian J Med Res; 1971 Feb; 59(2):251-8. PubMed ID: 4931412
[No Abstract] [Full Text] [Related]
7. Glibenclamide in the management of diabetes mellitus. I.
Devlin JG; Manning K; Harty J
J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
[No Abstract] [Full Text] [Related]
8. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
Torri A; Zanni A; Roncaia R; Di Saverio S
Clin Ter; 1977 Jul; 82(1):45-56. PubMed ID: 409583
[No Abstract] [Full Text] [Related]
9. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
Duncan LJ; Clarke BF; Munro JF
Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
[No Abstract] [Full Text] [Related]
10. Oral treatment of diabetes mellitus.
Chhetri MK
J Indian Med Assoc; 1968 May; 50(10):486-8. PubMed ID: 4883853
[No Abstract] [Full Text] [Related]
11. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
Beringer A
Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
[No Abstract] [Full Text] [Related]
12. [Antidiabetics. 42].
Jacker HJ
Pharm Prax; 1969 Dec; 12():270-9. PubMed ID: 4913446
[No Abstract] [Full Text] [Related]
13. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
Domingo Gutiérrez AJ
Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
[No Abstract] [Full Text] [Related]
14. [Oral differential therapy of diabetes mellitus].
Mehnert H
Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
[No Abstract] [Full Text] [Related]
15. [Glibenclamid in the treatment of diabetes mellitus].
Klein W
Dtsch Med J; 1970 Jul; 21(13):906-7. PubMed ID: 5509967
[No Abstract] [Full Text] [Related]
16. [A hypoglycemizing sulfamide associated with biguanide in the treatment of type I diabetes in adults].
Plauchu M; Thevenon P
Lyon Med; 1968 Oct; 220(42):953-63. PubMed ID: 5742623
[No Abstract] [Full Text] [Related]
17. Oral sulphonylureas in the management of diabetes.
Jackson WP
S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
[No Abstract] [Full Text] [Related]
18. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
Herman JB
Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
[No Abstract] [Full Text] [Related]
19. Clinical trial of glybenclamide, a hypoglycaemic agent.
Walker RL
Med J Aust; 1970 Nov; 2(22):1015-6. PubMed ID: 4924417
[No Abstract] [Full Text] [Related]
20. [Phenylethylbiguanide in the treatment of diabetes (apropos of 26 cases)].
Tourniaire J; Guinet P
Rev Lyon Med; 1965 Dec; 14(19):869-75. PubMed ID: 5864584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
